Home About us Editorial board Ahead of print Current issue Archives Submit article Instructions Referee Resource Subscribe
Export selected to
Reference Manager
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   2017| January-June  | Volume 4 | Issue 1  
    Online since March 16, 2018

  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
Tamoxifen for ovulation induction in infertile PCOS women who did not conceive with 3 or more cycles of clomiphene citrate: A prospective clinical study
Avanthi Gadipudi, Paapa Dasari, Haritha Sagili
January-June 2017, 4(1):22-29
Objectives: To assess the ovulatory, pregnancy rates and side effects of tamoxifen (TMX) in women who are infertile with polycystic ovarian syndrome (PCOS) and who did not conceive with three cycles of clomiphene citrate (CC). Study Design: A prospective interventional study. Population: Seventy-four women who were infertile with PCOS and who did not achieve pregnancy after a minimum of three cycles of CC were included in the study. Materials and Methods: TMX was given orally from Day 2 to Day 6 of the menstrual cycle, with a dose of 40 mg in the 1st cycle and 80 mg in the subsequent two cycles. Transvaginal ultrasound was used for follicular monitoring from Day 10 and on every alternate day till the day of ovulation or till the 20th day of the cycle. Statistical Analysis: Ovulation rates with different doses were compared using McNemar test. Kruskal–Wallis test was used to find out differences in maximum follicular diameter and endometrial thickness (ET) between 3 cycles. Results: The mean maximum follicular diameter was 16 ± 5.2 mm, and the mean ET was 8.9 ± 1.7 mm with an ovulatory rate of 41.90% with 40 mg of TMX. Mean increase in the maximum follicular diameters with 80 mg of TMX was higher when compared with 40 mg (P value − 0.000) of TMX. Increasing the dose of TMX in cycles 2 and 3 resulted in a statistically significant increase in the ovulatory rates; however, it was not so with ET. There were no clinical pregnancies, and minor side effects occurred in 14.1% of the participants. Conclusion: TMX induced ovulation only in 56% of the participants, and optimum ET was achieved in 92.7% of the participants; in addition, there were no pregnancies. Hence, TMX is not a useful ovulation inducing agent for CC failure/CC-resistant PCOS.
  11,989 427 -
Maternal and neonatal outcome of surviving twin after single fetal demise at 25 weeks: A rare case report
Mohan L Swarankar, Usha Shekhawat, Manisha Choudhary, Vinu Choudhary
January-June 2017, 4(1):30-34
Single fetal demise in twin pregnancy in late second or third trimester is a complex clinical situation and the management may face a dilemma. This is a rare case report of continuing pregnancy for 9 weeks in an intrauterine insemination (IUI) conceived dichorionic diamniotic twin pregnancy with intrauterine fetal demise of one twin at 25 weeks of gestation. A gravida 2 abortion 1 presented to Jaipur fertility centre (Department of Reproductive Medicine & Medical Genetics, MGUMST) with unexplained infertility of 3 years. She conceived with IUI at first attempt. The routine antenatal care scan at 25 weeks revealed 25 weeks 3 days single live fetus and second fetus 21 weeks with absent fetal heart pulsation and features of hydrops. The patient was hospitalized for conservative management. Regular follow-up was performed with daily fetal movement count, weekly coagulation profile, and ultrasound for fetal well-being. Inj. betamethasone was given for lung maturation at 32 weeks of gestation. She underwent caesarean section at 34 completed weeks for the preterm premature rupture of the membrane, the outcome being first fetus 2.2 kg female with Apgar score 7/10 and second macerated female fetus of 840 g. Postoperative period was uneventful for both mother and newborn. The baby was on regular check-up under a neonatologist. Her growth and neurological development was optimum according to her age group as seen on the long-term follow-up for 1 year.
  6,745 358 -
Microfluidics in andrology
Pankaj Talwar, Sapna Yadav
January-June 2017, 4(1):8-14
Male factor infertility is the sole cause of infertility in approximately 20% of the infertile couples with sperm playing a crucial role in the whole process of fertilization. Many technologies such as swim-up and density gradient techniques have been developed for the counting and sorting of sperms over the past few decades. Microfluidic technology was introduced into this field at the beginning of the 21st century. Studies have reported that conventional semen processing techniques have adverse effects on sperm deoxyribo nucleic acid (DNA) integrity leading to decreased pregnancy rates and are also associated with potential promutagenic alterations to sperm DNA. A gravity-driven microfluidic device, on the other hand, isolates motile sperms with good DNA integrity from seminal plasma, dead sperm, and debris, using microscale laminar flow without centrifugation. The objective of this review study is to evaluate whether microfluidic sperm sorters allow the effective recovery of sorted motile sperm without DNA damage compared with the centrifugation and swim-up procedure.
  4,588 525 -
Tobacco as a significant predictor of infertility: A public health perspective in an Indian scenario
Saumya Pandey, Kshitiz Murdia, Ajay Murdia
January-June 2017, 4(1):15-21
Introduction: Infertility is a major public health problem worldwide, including India. Tobacco consumption (smoking/chewing) is a significant predictor of metabolic perturbations in reproductive physiology, including infertility. The early identification of risk factors associated with infertility susceptibility in ethnically disparate population subsets is an attractive cost-effective strategy in infertility control, prevention, and management. Materials and Methods: A comprehensive literature search using PubMed and Medline scientific database(s) (last accessed November 4, 2017) was performed by the authors for the inclusion of most relevant articles in this review. Public health research studies for developing cost-effective infertility risk-assessment protocols in low-resource settings targeting couples who are infertile in India are ongoing for reducing the increasing burden of reproductive disorders and addressing the psychological/financial distress associated with the exorbitant cost of infertility treatment procedures, namely in-vitro fertilization. Results: With our clinical research experience in reproductive medicine/infertility, we strongly advocate the implementation of cost-effective community-based tobacco-cessation infertility management guidelines with robust public health research models in the specific population subsets of varying genetic landscapes and socioeconomic strata. Anti-tobacco public awareness campaigns should be organized for efficiently addressing health risks associated with tobacco consumption/cigarette smoking. Conclusion: The authors speculate that oxidative stress caused by tobacco in the physiological milieu may be diminished by therapeutically targeting specific metabolic/biochemical signaling pathways associated with cellular stress/death, immunomodulation, and inflammation. Biomarker development/validation for the stringent management of tobacco-mediated infertility will certainly provide spectacular gains in our current understanding of the pathophysiological basis of tobacco-related reproductive aberrations/disorders, primarily infertility, in the 21st century.
  4,705 271 -
Dilemmas in ART – Looking for solutions
Kuldeep Jain
January-June 2017, 4(1):1-7
  2,642 229 -
Oral Presentation

January-June 2017, 4(1):35-65
  2,381 156 -